MENU
+Compare
ANSLY
Stock ticker: OTC
AS OF
Sep 8 closing price
Price
$90.19
Change
+$1.62 (+1.83%)
Capitalization
3.29B

ANSLY stock forecast, quote, news & analysis

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment... Show more

ANSLY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ANSLY with price predictions
Feb 03, 2026

Momentum Indicator for ANSLY turns positive, indicating new upward trend

ANSLY saw its Momentum Indicator move above the 0 level on January 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 63 similar instances where the indicator turned positive. In of the 63 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for ANSLY just turned positive on February 03, 2026. Looking at past instances where ANSLY's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ANSLY moved below its 50-day moving average on January 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANSLY crossed bearishly below the 50-day moving average on January 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.625) is normal, around the industry mean (11.448). P/E Ratio (31.813) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.437). Dividend Yield (0.023) settles around the average of (0.017) among similar stocks. P/S Ratio (1.613) is also within normal values, averaging (111.001).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANSLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANSLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
published Dividends

ANSLY paid dividends on October 03, 2025

Ansell Ltd. ANSLY Stock Dividends
А dividend of $1.13 per share was paid with a record date of October 03, 2025, and an ex-dividend date of September 04, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.34B. The market cap for tickers in the group ranges from 246 to 169.76B. ISRG holds the highest valuation in this group at 169.76B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 23%. CBSC experienced the highest price growth at 87%, while GCTK experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 18%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 66
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
ANSLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
678 Victoria Street
Phone
+61 392707270
Employees
14414
Web
https://www.ansell.com